trending Market Intelligence /marketintelligence/en/news-insights/trending/mZ-RJznT5XkQ3sO-QDbM7w2 content esgSubNav
In This List

NeuroDerm closes public offering with $86.3M in gross proceeds

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

NeuroDerm closes public offering with $86.3M in gross proceeds

NeuroDerm Ltd. closed its offering of an additional 600,000 ordinary shares at a public offering price of $18.75.

The shares were sold pursuant to the full exercise of the underwriters' option to buy additional shares in connection with the company's follow-on offering of 4 million ordinary shares.

Total gross proceeds from the offering, including the initial issuance and the additional shares, were $86.3 million before underwriting discounts and commissions and other offering expenses.

Jefferies LLC and Cowen and Co. LLC acted as joint book-running managers, while Raymond James & Associates Inc. and Roth Capital Partners LLC acted as co-managers for the offering.